sec filing

NASDAQ · AVXL
Anavex Life Sciences Corp.
Healthcare · Biotechnology
$2.86
Up+$0.01 (+0.35%)
Updated Sep 8, 2026, 8:47 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 367.21M
- P/E ratio
- -7.28
- Dividend yield
- 0.00%
- 52-week range
- $2.26 – $10.40
- Volume
- 307.15K
- Avg. volume
- 2.3M
Price performance
AVXL price history
1M range · 20 trading sessions · Daily adjusted prices
AVXL closed at $2.86 after 20 trading sessions, down 15.63% for the selected period.
- Last close
- $2.86
- Period change
- -15.63%
- Period low
- $2.80
- Period high
- $3.56
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $2.82 | $2.905 | $2.81 | $2.86 | 307.15K |
| Sep 3, 2026 | $2.90 | $2.9399 | $2.82 | $2.85 | 421.92K |
| Sep 2, 2026 | $2.88 | $2.9784 | $2.815 | $2.89 | 587.45K |
| Sep 1, 2026 | $2.79 | $2.90 | $2.755 | $2.87 | 826.68K |
| Aug 31, 2026 | $2.95 | $2.97 | $2.78 | $2.80 | 1.03M |
| Aug 28, 2026 | $3.12 | $3.13 | $2.96 | $2.99 | 893.45K |
| Aug 27, 2026 | $3.248 | $3.26 | $3.12 | $3.13 | 652.7K |
| Aug 26, 2026 | $3.50 | $3.54 | $3.22 | $3.24 | 1.18M |
| Aug 25, 2026 | $3.37 | $3.6802 | $3.3651 | $3.56 | 2.48M |
| Aug 24, 2026 | $3.22 | $3.225 | $3.09 | $3.11 | 457.4K |
| Aug 21, 2026 | $3.17 | $3.29 | $3.16 | $3.24 | 480.79K |
| Aug 20, 2026 | $3.34 | $3.36 | $3.09 | $3.13 | 557.18K |
| Aug 19, 2026 | $3.20 | $3.41 | $3.20 | $3.39 | 655.29K |
| Aug 18, 2026 | $3.16 | $3.22 | $3.095 | $3.20 | 400.67K |
| Aug 17, 2026 | $3.19 | $3.23 | $3.152 | $3.21 | 464.79K |
| Aug 14, 2026 | $3.25 | $3.27 | $3.14 | $3.22 | 698.07K |
| Aug 13, 2026 | $3.40 | $3.40 | $3.22 | $3.27 | 829.93K |
| Aug 12, 2026 | $3.50 | $3.57 | $3.40 | $3.41 | 667.08K |
| Aug 11, 2026 | $3.37 | $3.54 | $3.36 | $3.51 | 662.62K |
| Aug 10, 2026 | $3.33 | $3.44 | $3.284 | $3.39 | 668.8K |
Latest AVXL news
The latest Smart Investors Daily articles mentioning AVXL.
Stock researchResearch & News · Competitors
Loading stock research…

